The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Dry Powder Inhaler Device-Global Market Insights and Sales Trends 2025
Synopsis
A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.
The global Dry Powder Inhaler Device market size is expected to reach US$ 1103.8 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029. The market is mainly driven by the significant applications of Dry Powder Inhaler Device in various end use industries. The expanding demands from the Asthma, COPD and Others,, are propelling Dry Powder Inhaler Device market. Single Dose, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Multi Dose segment is estimated at % CAGR for the next seven-year period.
GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, etc. are the key players in the global Dry Powder Inhaler Device market. Top 4 took up more than 30% of the global market.
From the view of region, USA have a larger consumption market share which account for about 35% of total share. Europe hold a market share of about 25%. In addition, Asia Pacific is also play important role in Global market.
Dry Powder Inhaler Device main application area is Asthma This sector hold a market share of over 80%. Then followed by the COPD.
According to the Segmentation of types, all the market of Dry Powder Inhaler Device can be divided as follows: Multi-dose, Single-dose.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Dry Powder Inhaler Device, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Dry Powder Inhaler Device market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Dry Powder Inhaler Device market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Dry Powder Inhaler Device sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Dry Powder Inhaler Device covered in this report include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind and Mylan, etc.
The global Dry Powder Inhaler Device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Mylan
Novartis
Schering/Merck
Teva
Vectura
Global Dry Powder Inhaler Device market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dry Powder Inhaler Device market, Segment by Type:
Single Dose
Multi Dose
Global Dry Powder Inhaler Device market, by Application
Asthma
COPD
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Dry Powder Inhaler Device manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Dry Powder Inhaler Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.
The global Dry Powder Inhaler Device market size is expected to reach US$ 1103.8 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029. The market is mainly driven by the significant applications of Dry Powder Inhaler Device in various end use industries. The expanding demands from the Asthma, COPD and Others,, are propelling Dry Powder Inhaler Device market. Single Dose, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Multi Dose segment is estimated at % CAGR for the next seven-year period.
GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, etc. are the key players in the global Dry Powder Inhaler Device market. Top 4 took up more than 30% of the global market.
From the view of region, USA have a larger consumption market share which account for about 35% of total share. Europe hold a market share of about 25%. In addition, Asia Pacific is also play important role in Global market.
Dry Powder Inhaler Device main application area is Asthma This sector hold a market share of over 80%. Then followed by the COPD.
According to the Segmentation of types, all the market of Dry Powder Inhaler Device can be divided as follows: Multi-dose, Single-dose.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Dry Powder Inhaler Device, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Dry Powder Inhaler Device market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Dry Powder Inhaler Device market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Dry Powder Inhaler Device sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Dry Powder Inhaler Device covered in this report include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind and Mylan, etc.
The global Dry Powder Inhaler Device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Mylan
Novartis
Schering/Merck
Teva
Vectura
Global Dry Powder Inhaler Device market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dry Powder Inhaler Device market, Segment by Type:
Single Dose
Multi Dose
Global Dry Powder Inhaler Device market, by Application
Asthma
COPD
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Dry Powder Inhaler Device manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Dry Powder Inhaler Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Dry Powder Inhaler Device Market Overview
1.1 Dry Powder Inhaler Device Product Overview
1.2 Dry Powder Inhaler Device Market Segment by Type
1.2.1 Single Dose
1.2.2 Multi Dose
1.3 Global Dry Powder Inhaler Device Market Size by Type
1.3.1 Global Dry Powder Inhaler Device Market Size Overview by Type (2018-2029)
1.3.2 Global Dry Powder Inhaler Device Historic Market Size Review by Type (2018-2023)
1.3.3 Global Dry Powder Inhaler Device Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Dry Powder Inhaler Device Sales Breakdown by Type (2018-2023)
1.4.2 Europe Dry Powder Inhaler Device Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Dry Powder Inhaler Device Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Dry Powder Inhaler Device Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Dry Powder Inhaler Device Sales Breakdown by Type (2018-2023)
2 Global Dry Powder Inhaler Device Market Competition by Company
2.1 Global Top Players by Dry Powder Inhaler Device Sales (2018-2023)
2.2 Global Top Players by Dry Powder Inhaler Device Revenue (2018-2023)
2.3 Global Top Players by Dry Powder Inhaler Device Price (2018-2023)
2.4 Global Top Manufacturers Dry Powder Inhaler Device Manufacturing Base Distribution, Sales Area, Product Type
2.5 Dry Powder Inhaler Device Market Competitive Situation and Trends
2.5.1 Dry Powder Inhaler Device Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Dry Powder Inhaler Device Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dry Powder Inhaler Device as of 2022)
2.7 Date of Key Manufacturers Enter into Dry Powder Inhaler Device Market
2.8 Key Manufacturers Dry Powder Inhaler Device Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Dry Powder Inhaler Device Status and Outlook by Region
3.1 Global Dry Powder Inhaler Device Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Dry Powder Inhaler Device Historic Market Size by Region
3.2.1 Global Dry Powder Inhaler Device Sales in Volume by Region (2018-2023)
3.2.2 Global Dry Powder Inhaler Device Sales in Value by Region (2018-2023)
3.2.3 Global Dry Powder Inhaler Device Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Dry Powder Inhaler Device Forecasted Market Size by Region
3.3.1 Global Dry Powder Inhaler Device Sales in Volume by Region (2024-2029)
3.3.2 Global Dry Powder Inhaler Device Sales in Value by Region (2024-2029)
3.3.3 Global Dry Powder Inhaler Device Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Dry Powder Inhaler Device by Application
4.1 Dry Powder Inhaler Device Market Segment by Application
4.1.1 Asthma
4.1.2 COPD
4.1.3 Others
4.2 Global Dry Powder Inhaler Device Market Size by Application
4.2.1 Global Dry Powder Inhaler Device Market Size Overview by Application (2018-2029)
4.2.2 Global Dry Powder Inhaler Device Historic Market Size Review by Application (2018-2023)
4.2.3 Global Dry Powder Inhaler Device Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Dry Powder Inhaler Device Sales Breakdown by Application (2018-2023)
4.3.2 Europe Dry Powder Inhaler Device Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Dry Powder Inhaler Device Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Dry Powder Inhaler Device Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Dry Powder Inhaler Device Sales Breakdown by Application (2018-2023)
5 North America Dry Powder Inhaler Device by Country
5.1 North America Dry Powder Inhaler Device Historic Market Size by Country
5.1.1 North America Dry Powder Inhaler Device Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Dry Powder Inhaler Device Sales in Volume by Country (2018-2023)
5.1.3 North America Dry Powder Inhaler Device Sales in Value by Country (2018-2023)
5.2 North America Dry Powder Inhaler Device Forecasted Market Size by Country
5.2.1 North America Dry Powder Inhaler Device Sales in Volume by Country (2024-2029)
5.2.2 North America Dry Powder Inhaler Device Sales in Value by Country (2024-2029)
6 Europe Dry Powder Inhaler Device by Country
6.1 Europe Dry Powder Inhaler Device Historic Market Size by Country
6.1.1 Europe Dry Powder Inhaler Device Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Dry Powder Inhaler Device Sales in Volume by Country (2018-2023)
6.1.3 Europe Dry Powder Inhaler Device Sales in Value by Country (2018-2023)
6.2 Europe Dry Powder Inhaler Device Forecasted Market Size by Country
6.2.1 Europe Dry Powder Inhaler Device Sales in Volume by Country (2024-2029)
6.2.2 Europe Dry Powder Inhaler Device Sales in Value by Country (2024-2029)
7 Asia-Pacific Dry Powder Inhaler Device by Region
7.1 Asia-Pacific Dry Powder Inhaler Device Historic Market Size by Region
7.1.1 Asia-Pacific Dry Powder Inhaler Device Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Dry Powder Inhaler Device Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Dry Powder Inhaler Device Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Dry Powder Inhaler Device Forecasted Market Size by Region
7.2.1 Asia-Pacific Dry Powder Inhaler Device Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Dry Powder Inhaler Device Sales in Value by Region (2024-2029)
8 Latin America Dry Powder Inhaler Device by Country
8.1 Latin America Dry Powder Inhaler Device Historic Market Size by Country
8.1.1 Latin America Dry Powder Inhaler Device Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Dry Powder Inhaler Device Sales in Volume by Country (2018-2023)
8.1.3 Latin America Dry Powder Inhaler Device Sales in Value by Country (2018-2023)
8.2 Latin America Dry Powder Inhaler Device Forecasted Market Size by Country
8.2.1 Latin America Dry Powder Inhaler Device Sales in Volume by Country (2024-2029)
8.2.2 Latin America Dry Powder Inhaler Device Sales in Value by Country (2024-2029)
9 Middle East and Africa Dry Powder Inhaler Device by Country
9.1 Middle East and Africa Dry Powder Inhaler Device Historic Market Size by Country
9.1.1 Middle East and Africa Dry Powder Inhaler Device Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Dry Powder Inhaler Device Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Dry Powder Inhaler Device Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Dry Powder Inhaler Device Forecasted Market Size by Country
9.2.1 Middle East and Africa Dry Powder Inhaler Device Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Dry Powder Inhaler Device Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GlaxoSmithKline Dry Powder Inhaler Device Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Introduction and Business Overview
10.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2018-2023)
10.2.4 AstraZeneca Dry Powder Inhaler Device Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information
10.3.2 Boehringer Ingelheim Introduction and Business Overview
10.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Boehringer Ingelheim Dry Powder Inhaler Device Products Offered
10.3.5 Boehringer Ingelheim Recent Development
10.4 Chiesi
10.4.1 Chiesi Company Information
10.4.2 Chiesi Introduction and Business Overview
10.4.3 Chiesi Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Chiesi Dry Powder Inhaler Device Products Offered
10.4.5 Chiesi Recent Development
10.5 Cipla
10.5.1 Cipla Company Information
10.5.2 Cipla Introduction and Business Overview
10.5.3 Cipla Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Cipla Dry Powder Inhaler Device Products Offered
10.5.5 Cipla Recent Development
10.6 3M
10.6.1 3M Company Information
10.6.2 3M Introduction and Business Overview
10.6.3 3M Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2018-2023)
10.6.4 3M Dry Powder Inhaler Device Products Offered
10.6.5 3M Recent Development
10.7 Hovione
10.7.1 Hovione Company Information
10.7.2 Hovione Introduction and Business Overview
10.7.3 Hovione Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Hovione Dry Powder Inhaler Device Products Offered
10.7.5 Hovione Recent Development
10.8 Mannkind
10.8.1 Mannkind Company Information
10.8.2 Mannkind Introduction and Business Overview
10.8.3 Mannkind Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Mannkind Dry Powder Inhaler Device Products Offered
10.8.5 Mannkind Recent Development
10.9 Mylan
10.9.1 Mylan Company Information
10.9.2 Mylan Introduction and Business Overview
10.9.3 Mylan Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Mylan Dry Powder Inhaler Device Products Offered
10.9.5 Mylan Recent Development
10.10 Novartis
10.10.1 Novartis Company Information
10.10.2 Novartis Introduction and Business Overview
10.10.3 Novartis Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Novartis Dry Powder Inhaler Device Products Offered
10.10.5 Novartis Recent Development
10.11 Schering/Merck
10.11.1 Schering/Merck Company Information
10.11.2 Schering/Merck Introduction and Business Overview
10.11.3 Schering/Merck Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Schering/Merck Dry Powder Inhaler Device Products Offered
10.11.5 Schering/Merck Recent Development
10.12 Teva
10.12.1 Teva Company Information
10.12.2 Teva Introduction and Business Overview
10.12.3 Teva Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Teva Dry Powder Inhaler Device Products Offered
10.12.5 Teva Recent Development
10.13 Vectura
10.13.1 Vectura Company Information
10.13.2 Vectura Introduction and Business Overview
10.13.3 Vectura Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Vectura Dry Powder Inhaler Device Products Offered
10.13.5 Vectura Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Dry Powder Inhaler Device Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Dry Powder Inhaler Device Industrial Chain Analysis
11.4 Dry Powder Inhaler Device Market Dynamics
11.4.1 Dry Powder Inhaler Device Industry Trends
11.4.2 Dry Powder Inhaler Device Market Drivers
11.4.3 Dry Powder Inhaler Device Market Challenges
11.4.4 Dry Powder Inhaler Device Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Dry Powder Inhaler Device Distributors
12.3 Dry Powder Inhaler Device Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
